ValuationViz

KYMR fund manager activity

Kymera Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q3 2024 to Q2 2026.

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded20,000$1,556,2000.00%Feb 17, 2026

Q3 2025

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalNew7,000$396,2000.00%Nov 14, 2025

Newer quarters · Older quarters